When those EVs where administered to cancer-associated fibroblasts (CAF) derived from breast cancer patients, an upregulation in the transcription of c-Myc-dependent genes was observed, while MXI1 (a MAX-interacting protein) was downregulated. This evidence concerns the gene MYC and cancer.